GSE155031 6 V 2 DEXTRAN HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE155031 6 V 2 DEXTRAN HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE155031 6 V 2 DEXTRAN HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE155031 6 V 2 DEXTRAN HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE155031 6 V 2 DEXTRAN HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

H3 clustered histone 7

Gene

armadillo like helical domain containing 3

Gene

cap methyltransferase 1

Gene

zinc finger CW-type and PWWP domain containing 1

Gene

spermatogenesis associated 18

Gene

shiftless antiviral inhibitor of ribosomal frameshifting

Gene

popeye domain cAMP effector 1

Gene

G protein-coupled receptor 179

Gene

leucine rich repeat containing 37B

  • Gene

    H4 clustered histone 15


  • Gene

    H3 clustered histone 7


  • Gene

    armadillo like helical domain containing 3


  • Gene

    cap methyltransferase 1


  • Gene

    zinc finger CW-type and PWWP domain containing 1


  • Gene

    spermatogenesis associated 18


  • Gene

    shiftless antiviral inhibitor of ribosomal frameshifting


  • Gene

    popeye domain cAMP effector 1


  • Gene

    G protein-coupled receptor 179


  • Gene

    leucine rich repeat containing 37B

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.